ProMIS Neurosciences (NASDAQ:PMN) Announces Quarterly Earnings Results

ProMIS Neurosciences (NASDAQ:PMN) issued its quarterly earnings results on Tuesday. The company reported ($0.19) earnings per share for the quarter, reports.

ProMIS Neurosciences Stock Up 2.8 %

Shares of NASDAQ:PMN opened at $1.85 on Friday. ProMIS Neurosciences has a fifty-two week low of $0.95 and a fifty-two week high of $8.95. The firm’s 50-day simple moving average is $2.00 and its 200-day simple moving average is $1.79.

Institutional Trading of ProMIS Neurosciences

An institutional investor recently bought a new position in ProMIS Neurosciences stock. Affinity Asset Advisors LLC bought a new stake in ProMIS Neurosciences, Inc. (NASDAQ:PMN) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 265,958 shares of the company’s stock, valued at approximately $527,000. Affinity Asset Advisors LLC owned approximately 3.10% of ProMIS Neurosciences at the end of the most recent quarter. 50.13% of the stock is currently owned by institutional investors.

ProMIS Neurosciences Company Profile

ProMIS Neurosciences, Inc discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins.